Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients.
Aryl hydrocarbon hydroxylase (AHH) inducibility and lymphoblast formation were studied in lymphocytes from healthy control subjects and from lung cancer patients undergoing radiotherapy. The relationship between AHH inducibility and percentage lymphoblasts was statistically significant only for the pre-treatment patients (r = 0.598; p less than 0.05). In the control group and in patients undergoing radiotherapy the correlation between AHH inducibility and lymphoblast formation was positive but statistically it was not significant. Our data do not suggest a linear relationship between AHH inducibility and lymphoblast formation.
D001189:Aryl Hydrocarbon Hydroxylases / Q000096:biosynthesis*; D004790:Enzyme Induction; D006801:Humans; D008175:Lung Neoplasms / Q000201:enzymology* / Q000276:immunology / Q000532:radiotherapy; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged
D001189:Aryl Hydrocarbon Hydroxylases